Barclays PLC
07 October 2004
7 October 2004
Notification of directors' interests: Companies Act 1985 s.329
The Company was notified on 6 October 2004 by the Administrators of the Dividend
Reinvestment Plan (the 'Plan') that on 1 October 2004 the following directors
had received ordinary shares in the Company under the Plan for the 2004 interim
dividend at a price of 539.68p per share. The number of shares received by each
director, together with their total beneficial interests following the
allotments are as follows:
Director No. of shares Beneficial Interest
received
MW Barrett 4,313 289,242
Sir Richard Broadbent 43 3,992
SG Russell 36 13,774
DL Roberts 1 62,315
Following these transactions, the trustees of all the Barclays Group employees'
benefit trusts hold a total of 112,898,982 ordinary shares in Barclays PLC.
Matthew Barrett, Chairman, and the executive directors of Barclays PLC are
amongst the potential beneficiaries under these trusts and are therefore
regarded for Companies Act purposes as being interested in the Barclays PLC
ordinary shares held in them.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.